| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Zealand Pharma, OTR Therapeutics Sign Deal to Develop Metabolic Disease Treatments | ||
| Fr | Lilly to Invest $6B in New API Manufacturing Facility in Alabama | ||
| Do | Developer of 'Physical AI Scientists' Raises $52M | ||
| Do | Charles River Announces Latest Cohort of Its Cell & Gene Therapy Incubator Program | ||
| Mi | Cytiva, Fidabio Partner to Expand Analytical Capabilities for Protein Research | ||
| Mi | The Wellcome Sanger Institute Selects Sapio Informatics as Its Central LIMS | ||
| Mi | Advarra Expands Its Network of Partner Applications | ||
| Mi | Tjoapack Invests in New 170,000-Square-Foot Facility in Tennessee | ||
| Mi | Expression Therapeutics Taps Former Pfizer, Novartis Exec as CEO | ||
| Mi | Zydus & Formycon Partner for Keytruda Biosimilar in US & Canada | ||
| Di | Bora Pharmaceuticals, Corealis Pharma Partner to Provide End-to-End Services | ||
| Di | Ability Biotherapeutics Appoints Dr. Angele Maki as Chief Business Officer | ||
| Di | Marchesini Group, AST Partner to Expand Capacity and Global Network | ||
| Di | ProBioGen, Spica Therapeutics Partner to Advance ST101 | ||
| Di | BenchSci Extends ASCEND Agreement with Merck | ||
| Di | Cellular Origins Completes $40M Series A Round | ||
| Di | Pfizer, YaoPharma Enter Exclusive Collaboration and License Agreement | ||
| Mo | Mirum Pharmaceuticals to Acquire Bluejay Therapeutics | ||
| 05.12. | Natera Acquires Foresight Diagnostics | ||
| 05.12. | FDA Approves Bristol Myers Squibb's Breyanzi for Marginal Zone Lymphoma | ||
| 05.12. | Jubilant Therapeutics Appoints New President & CEO | ||
| 04.12. | Quotient Sciences, Intrepid Labs Partner to Advance AI in Early Drug Development | ||
| 04.12. | Trevi Therapeutics Taps David Hastings as CFO | ||
| 04.12. | Neurimmune Expands ATTR-CM Collaboration with AstraZeneca | ||
| 03.12. | IWK Introduces Machine to Produce 100% Cardboard Blister Packaging |